Antifungal immune responses:emerging host-pathogen interactions and translational implications by Kumar, Vinod et al.
  
 University of Groningen
Antifungal immune responses





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2018
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kumar, V., van de Veerdonk, F. L., & Netea, M. G. (2018). Antifungal immune responses: emerging host-
pathogen interactions and translational implications. Genome medicine, 10(1), [39].
https://doi.org/10.1186/s13073-018-0553-2
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Kumar et al. Genome Medicine  (2018) 10:39 
https://doi.org/10.1186/s13073-018-0553-2COMMENT Open AccessAntifungal immune responses: emerging
host–pathogen interactions and
translational implications
Vinod Kumar1,2*, Frank L. van de Veerdonk2 and Mihai G. Netea2,3*Editorial summary
Understanding the complex and highly dynamic
interactions between fungi and host cells in a tissue-
specific manner is crucial to facilitate the development
of new therapeutic approaches to infections. Here, we
discuss recent studies that are revealing the mecha-
nisms underlying this context-dependent interplay.Fungal pathogens present a variety ofThe mycobiome, fungal infections, and immunity
Fungi are common inhabitants of human barrier sur-
faces such as the oral cavity, skin, vagina, gut, and lungs.
Altered immune status, usually due to treatment with
immunosuppressive drugs and sometimes caused by
inherited deficiencies in host defense, leads to increased
susceptibility to fungal infections. Invasive fungal infec-
tions are associated with high mortality rates with an es-
timated 1.5 million deaths globally each year. Mucosal
infections are more prevalent than invasive infections
and are a major cause of morbidity. In contrast to bac-
terial and viral infections, an effective vaccine against
fungal infections has not been developed, and currently
available antifungal drugs are only partly successful in
treating patients with invasive fungal infections. Im-
munological and genetic studies indicate a crucial role of
human immune defects in fungal infections. Therefore,
identification of appropriate prophylactic and immuno-
therapeutic targets has been considered the most prom-
ising strategy to overcome morbidity and mortality.
Most invasive fungal infections are caused by species
from three genera: Candida, Aspergillus, and Cryptococcus.* Correspondence: v.kumar@umcg.nl; mihai.netea@radboudumc.nl
1University of Groningen, University Medical Center Groningen, Department
of Genetics, 9700 RB Groningen, The Netherlands
2Department of Internal Medicine and Radboud Center for Infectious
Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The
Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeThese fungi can exist in two morphological forms: yeasts
(unicellular forms that reproduce asexually by conidia for-
mation) and hyphae (multicellular forms with branching,
tubular filaments), which have different cell wall composi-
tions. The hyphal morphotype is usually associated with tis-
sue invasion whereas the conidial form is associated with
colonization, which suggests differential host recognition
and explains the contrast in virulence.
pathogen-associated molecular patterns (PAMPs) that
may require a unique set of pattern recognition recep-
tors (PRRs) from host cells to recognize and activate
distinct downstream immune responses (Table 1). In-
nate immune cells such as dendritic cells, monocytes,
macrophages, and neutrophils are known to express an
array of PRRs to recognize fungal infections, to induce
protective responses, and to activate adaptive immun-
ity. Roles for different PRRs such as C-type lectin re-
ceptors (CLRs), Toll-like receptors (TLRs), and
NOD-like receptors (NLRs) in sensing fungal infection
and triggering appropriate anti-fungal responses have
been established (reviewed in [1]). However, the diverse
morphological adaptations (such as conidial and hyphal
forms) among fungal pathogens during their interaction
with the host immune system, in different tissue com-
partments and/or different environmental conditions,
have hampered efforts to identify therapeutic targets.
Recent genetic, genomic, and experimental studies are
providing insights into the underlying
context-dependent immune mechanisms against fungal
infections and the evasion strategies utilized by fungal
pathogens, as well as novel host and pathogen targets
for the development of potential therapies.Host–pathogen interactions in antifungal
immunity
The cell wall of Aspergillus fumigatus contains an im-
munologically active ligand called melanin. In an elegantle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Human pattern recognition receptors and cell types involved in antifungal immune responses (reviewed in [1])
Fungal pathogen Routes of infection Key PAMPs PRRs Cell types that express PRRs





TLRs (− 2, −4), CLRs (dectin-1, − 2,
mincle [7], MR, DC-SIGN, Mcl), NLRs
(NLRP3, 4,10), CR3, FcγR, galectin-3,
MDA5
Monocytes, macrophages, dendritic cells,
neutrophils, mast cells, subset of T cells,
B cells, endothelial cells, epithelial cells,
gut resident CX3CR1+ mononuclear
phagocytes [7]
Aspergillus fumigatus Lung β-1,3-glucan, chitin,
galactomannan,
DHN-melanin [2]
TLR2, CLRs (dectin-1, − 2, mincle,
DC-SIGN), NLRs (NOD1, NLRP3),
CR3, PTX3 [3–5], MelLec [2]
Airway epithelial cells, CCR2+ monocytes
[9], macrophages, dendritic cells [5], T
and B cells, endothelial cells
Cryptococcus neoformans Lung Mannose, capsular
polysaccharide,
glucuronoxylomannan
TLRs (−2,-4), CLRs (dectin-2, MR),
NLRs (NLRP3)
Macrophages, endothelial cells
CLR C-type lectin receptor, CR3 complement receptor 3, Fcγ receptor, NLR NOD-like receptor, MR mannose receptor, MDA5 Melanoma differentiation factor 5,
PAMPs pathogen-associated molecular patterns, PRRs pattern recognition receptors
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MelLec, encoded by the CLEC1A gene, is a
melanin-sensing CLR, using mouse models and human
subjects. This receptor recognizes the naphthalene-diol
unit of 1,8-dihydroxynaphthalene (DHN)-melanin present
only in conidial spores of A. fumigatus and other fungi
containing DHN-melanin, but not Candida albicans or
Saccharomyces cerevisiae, which highlights the importance
of microbial ligand specificity. MelLec is specifically
expressed in mouse endothelial cells, whereas in humans
it is ubiquitously expressed in endothelial and myeloid
cells. Importantly, a single nucleotide polymorphism
(SNP) in the CLEC1A gene of human donors that resulted
in an amino acid polymorphism (Gly26Ala) in MelLec in-
creased the risk of disseminated Aspergillus infections in
hematopoietic stem-cell transplant recipients, but this risk
was not dependent on recipient SNP genotype. It will be
interesting to test whether this polymorphism plays a role
in distinct fungal infections in different tissues, which may
help to address the question of whether the protection is
driven by a pathogen- and/or tissue-specific function of
this receptor. Pentraxin 3 (PTX3) is a secreted PRR that is
also crucial for host defense against A. fumigatus [3]. Re-
cently, polymorphisms in the human PTX3 gene have also
been associated with aspergillosis in patients undergoing
hematopoietic stem cell transplantation [4]. Furthermore,
downregulation of PTX3 in dendritic cells caused by im-
paired calcineurin signaling results in higher susceptibility
of mice to invasive pulmonary aspergillosis [5]. Adminis-
tration of PTX3 restores antifungal host responses in
humans and mice, but more studies are needed to under-
stand the precise mechanism underlying how PTX3 coor-
dinates the host response against aspergillosis in humans.
Shlezinger et al. [6] unraveled a novel mechanism that
underlies how neutrophils in the lung kill A. fumigatus
conidia, and, conversely, how A. fumigatus evades this
process. Neutrophils trigger fungal caspase-dependent
programmed cell death in the conidia by producing
NADPH oxidase, which results in the production of re-
active oxygen species and fungal cell death. To evadehost-induced programmed cell death A. fumigatus ex-
presses the gene AfBir1. This gene is homologous to the
human Survivin gene, which contains a BIR domain that
is involved in the suppression of apoptosis by caspase in-
hibition. These findings highlight the potential for iden-
tifying drug targets in the pathogen genome, and suggest
that inhibition of A. fumigatus AfBir1 could be used to
treat invasive aspergillosis, to induce programmed cell
death in conidia and improve host survival.
In the human gut, CLRs dectin-1 and dectin-3 are PRRs
that have been shown to be important in mediating
anti-fungal responses to intestinal fungi (gut mycobiota).
Leonardi et al. [7] determined the cell type involved in the
regulation of anti-fungal immunity in the intestine. Upon
colonization of mouse intestine with C. albicans, several
fungal PRRs such as dectin-1, dectin-2, and mincle were
more highly expressed in gut-resident CX3CR1+ mono-
nuclear phagocytes (MNPs) than in dendritic cells. Den-
dritic cells were previously shown to be important for host
defense against fungal infections in the lung. Specific de-
pletion of CX3CR1+ MNPs in mice resulted in a reduction
in anti-fungal Th17 cells and in IgG antibody responses
against intestinal C. albicans but not against systemic in-
fection. Thus, CX3CR1+ MNPs were specifically involved
in innate and adaptive immune responses to intestinal
fungi. These findings underscore the importance of
tissue-specific cellular functions in fungal infections. Leo-
nardi et al. [7] also investigated the effect of genetic varia-
tions in the human CX3CR1 gene on immunity to fungal
infections in patients with inflammatory bowel disease. It
is conceivable that because of the immunosuppression
treatment strategy used for patients with inflammatory
bowel disease, there is an increased risk of intestinal and
extra-intestinal fungal infections. A coding polymorphism
in CX3CR1 in patients with Crohn’s disease was associated
with impaired ability to produce antibodies against mul-
tiple gut fungal species. These findings further identified a
role for CX3CR1+ MNPs in antifungal immune responses
during inflammatory disease. Whether targeting specific
cell types such as CX3CR1+ MNPs to generate effective
Kumar et al. Genome Medicine  (2018) 10:39 Page 3 of 3antibody responses against pathogenic fungi would be ef-
fective in Crohn’s disease patients remains a question for
future studies.
Regulation of the antifungal immune response involves
coordinated function of many different cell types.
Neutrophils and monocytes, which have essential roles
in building and modulating the innate immune response,
are particularly important in eliminating fungal patho-
gens, and their roles in regulating interferon (IFN) re-
sponses have also been highlighted recently. Using an
in vitro infection model and genomics approach, we and
others previously showed that the type I interferon (IFN
α and β) pathway is strongly activated in response to C.
albicans infection in human peripheral blood mono-
nuclear cells (which included monocytes and lympho-
cytes but not neutrophils) [8]. Also, a recent study by
Espinosa et al. [9] uncovered another interferon path-
way, namely type III IFNs (IFN-λs), as a crucial regulator
of antifungal neutrophil responses against A. fumigatus.
The study also emphasized the importance of
context-dependent cellular communication, in which a
subset of pulmonary monocytes that express chemokine
receptor CCR2 (CCR2+ monocytes) together with neu-
trophils regulate both type I and type III interferon re-
sponses for efficient antifungal responses. In contrast to
the antifungal role of gut-resident CX3CR1+ MNPs
identified by Leonardi et al. [7], the CCR2+ pulmonary
monocytes were important for the antifungal response
in the lung [9]. Although the exact cell type that pro-
duces IFN-λ is still unknown, observations from survival
studies in CCR2-depleted mice upon treatment with
IFN-α and IFN-λ cytokines suggest that recombinant
cytokine therapies can enhance protective IFN responses
and antifungal immunity and could provide potential
therapeutic benefits [9].Conclusions and future directions
Recent studies have provided important insights into the
mechanistic basis for the cellular and organ specificity of
host immune responses against fungi, the receptors and
pathways involved, and how alterations in these pathways
can confer susceptibility to fungal infections in humans.
Furthermore, cytokine responses in human peripheral
blood mononuclear cells against different fungal and bac-
terial stimulations have been shown to be strongly
dependent on cell type and pathogen type [10]. However,
much remains to be discovered about these mechanisms.
Considering the context-dependent regulation of antifun-
gal responses, future studies should focus on systems ap-
proaches to comprehensively identify the specific cell types
and host and pathogen factors that are involved in orches-
trating effective antifungal host responses. Nevertheless,
these recent discoveries are stepping-stones towards thedesign and introduction of effective adjuvant immunother-
apy for the treatment of fungal infections.
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